Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 763
Aptamer sequence: GAGUGCGCCCAUUGAUAAGAGCGUAGGUUCAACGGAGUCGUAGUCGUUCUCAAGUUGACGGUGCAUUAGAGUCCU
Target unique ID: 6140
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_696 518 Molecule Phenylalanine 0.48 mM 50 mM Hepes (pH 7.0), 0.3 M NaCl, 5 mM CaCl2, and 5 mM MgCl2 11847556
Structure information of aptamer
Aptamer Sequence: GAGUGCGCCCAUUGAUAAGAGCGUAGGUUCAACGGAGUCGUAGUCGUUCUCAAGUUGACGGUGCAUUAGAGUCCU
The optimal secondary structure in dot-bracket notation: .((((((((..(((((.((((((..(((((....))))).....))))))...))))).))))))))........
The centroid secondary structure in dot-bracket notation: .((((((((..................................................))))))))........
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_696 Description 518
Aptamer chemistry RNA Length 75 nt
GC content 50.7% Molecular weight 24,175.31 Da
Molarity of 1 μg/μl solution 41.36 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Aptasensor
Sequence GAGUGCGCCCAUUGAUAAGAGCGUAGGUUCAACGGAGUCGUAGUCGUUCUCAAGUUGACGGUGCAUUAGAGUCCU
Applications Determination of phenylalanine
Target information
Type Detail Type Detail
PubChem ID 6140 Molecular name Phenylalanine
Molecular formula C9H11NO2 Molecular weight 165.19
IUPAC name (2S)-2-amino-3-phenylpropanoic acid InChIKey COLNVLDHVKWLRT-QMMMGPOBSA-N
LogP 0.641 Topological polar surface area 63.32
Hydrogen bond acceptor 2 Hydrogen bond donor 2

Synonym(s):
L-phenylalanine; phenylalanine; 63-91-2; (S)-2-Amino-3-phenylpropanoic acid; 3-Phenyl-L-alanine; (2S)-2-amino-3-phenylpropanoic acid; (S)-Phenylalanine; (S)-2-Amino-3-phenylpropionic acid; beta-Phenyl-L-alanine; (L)-Phenylalanine; 3-Phenylalanine; H-Phe-OH; Antibiotic FN 1636; L-Alanine, phenyl-; Alanine, 3-phenyl-; L-Antibiotic FN 1636; (S)-alpha-Amino-beta-phenylpropionic acid; L-Alanine, 3-phenyl-; Phenylalanine (VAN); Fenilalanina [Spanish]; Phenylalaninum [Latin]; (S)-alpha-Aminohydrocinnamic acid; Alanine, phenyl-, L-; (S)-(-)-Phenylalanine; beta-Phenylalnine, (-)-; (S)-alpha-Amino-benzenepropanoic acid; FEMA No. 3585; Phenylalanine, L-; Hydrocinnamic acid, alpha-amino-; 2-Amino-3-phenylpropionic acid, L-; Phenylalanine [USAN:INN:JAN]; HSDB 1825; alpha-Aminohydrocinnamic acid, L-; alpha-Amino-beta-phenylpropionic acid, L-; Benzenepropanoic acid, alpha-amino-, (S)-; fenilalanina; alpha-Aminohydrocinnamic acid; endophenyl; NSC 79477; L-Phe; UNII-47E5O17Y3R; L-PHENYLALININE; MFCD00064227; 67675-33-6; CHEMBL301523; CHEBI:17295; L-2-Amino-3-phenylpropionic acid; phe; 47E5O17Y3R; Phenylalaninum; phenylalanin; Phenylalamine; Phenylalanine (L-Phenylalanine); Alanine, phenyl-; .beta.-Phenylalanine; Phenyl-.alpha.-alanine; L-.beta.-Phenylalanine; .beta.-Phenyl-L-alanine; (-)-.beta.-Phenylalanine; EINECS 200-568-1; .alpha.-Aminohydrocinnamic acid; .beta.-Phenyl-.alpha.-alanine; Phenylalanine (USP/INN); L-phenylaniline; Hydrocinnamic acid, .alpha.-amino-; NSC-9959; CCRIS 4254; .beta.-Phenyl-.alpha.-alanine, l-; NSC-79477; L-phenyl Alanine; PheOH; 1usi; NCI9959; (-)-phenylalanine; .alpha.-Amino-.beta.-phenylpropionic acid; racemic phenylalanine; Phenylalanine [USAN:USP:INN:JAN]; 1f2p; alpha-Aminohydrocinnamate; (-)-beta-Phenylalanine; L-Phenylalanine, 99%; beta-Phenyl-alpha-alanine; L-Phenylalanine (JP17); bmse000045; bmse000900; bmse000921; bmse001016; SCHEMBL8119; NCIStruc1_000204; NCIStruc2_000248; H-Phe-2-Chlorotrityl Resin; L-(-)-PHENYLALANINE; (S)-alpha-Aminohydrocinnamate; L-Phenylalanine (H-Phe-OH); L-2-Amino-3-phenylpropionate; L-Phenylalanine, 99%, FCC; GTPL3313; (S)-alpha-Aminobenzenepropanoate; 3-Amino-4-phenyl-butanoic acid; DTXSID4040763; (S)-2-amino-3-phenylpropanoate; BDBM18073; (S)-2-Amino-3-phenylpropionate; 1F9436B3-8B0D-4AC6-A004-4249B0BDA436; L-Phenylalanine non-animal source; (S)-alpha-Amino-benzenepropanoate; ZINC105196; HY-N0215; L-2-amino-3-phenyl-propionic acid; (S)-alpha-Aminobenzenepropanoic acid; AC8117; CCG-37572; NCGC00013103; L-[2,3,4,5,6-3H]phenylalanine; (S)-alpha-Amino-beta-phenylpropionate; AKOS010373257; AKOS015853585; L-Phenylalanine, Cell Culture Reagent; (S)-.alpha.-Aminobenzenepropanoic acid; DB00120; L-Phenylalanine, Vetec(TM), 98.5%; MCULE-5960921520; L-Phenylalanine, reagent grade, >=98%; NCGC00013103-02; NCGC00013103-03; NCGC00013103-04; NCGC00013103-05; NCGC00095047-01; NCGC00095047-02; NCGC00095047-03; NCGC00095047-04; AC-22417; AS-14129; BP-20538; K018; AB0013977; DB-029978; L-Phenylalanine, 99%, natural, FCC, FG; AM20060774; P0134; Benzenepropanoic acid, .alpha.-amino-, (S)-; L-Phenylalanine, BioUltra, >=99.0% (NT); 63P912; A20654; C00079; D00021; M02961; 34149-EP2289892A1; 34149-EP2301939A1; 34149-EP2305688A1; 34149-EP2305825A1; 34149-EP2311850A1; L-Phenylalanine, SAJ special grade, >=99.0%; 125851-EP2284178A2; 125851-EP2284179A2; 125851-EP2295422A2; Q170545; L-Phenylalanine, Vetec(TM) reagent grade, >=98%; Q-201326; F0001-2360; Z1258578341; L-Phenylalanine, certified reference material, TraceCERT(R); UNII-0O72R8RF8A component COLNVLDHVKWLRT-QMMMGPOBSA-N; UNII-8P946UF12S component COLNVLDHVKWLRT-QMMMGPOBSA-N; UNII-N7U7BXP2OI component COLNVLDHVKWLRT-QMMMGPOBSA-N; Phenylalanine, European Pharmacopoeia (EP) Reference Standard; 3-(2-AMINOETHYL)-1,3-THIAZOLIDINE-2,4-DIONEHYDROCHLORIDE; L-Phenylalanine, United States Pharmacopeia (USP) Reference Standard; L(-)-phenylalanine; Beta-phenylalanine;Dl-2-amino-3-phenylpropanoic acid;; L-Phenylalanine, analytical standard, for Nitrogen Determination According to Kjeldahl Method; L-Phenylalanine, Pharmaceutical Secondary Standard; Certified Reference Material; L-Phenylalanine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%; L-Phenylalanine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture

Activity data
Interaction ID 763
Target type Molecule
Target unique ID 6140
Activity 0.48 mM
Binding Conditions/Buffer

50 mM Hepes (pH 7.0), 0.3 M NaCl, 5 mM CaCl2, and 5 mM MgCl2

Assay

Elution of RNA 518 from ligand–Sepharose. Filled squares, Phe–Sepharose; filled circles, OAc–Sepharose

PubMed ID 11847556
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_353 RNA GAAUUCCGCGUGUGCCAGCGAAAGUUGCGUAUGGGUCACAUCGCAGGCACAUGUCAUCUGGGCGGUCCGUUCGGGAUCC 55.70%
Apta_1223 RNA GGAGGCGCCAACUGAAUGAAAGGUUACGCUUCAACGCCGUGCAGCUGCUUCGGCAGGCUUGUGAGUACAUGGCCCAUUGAUCCGUAACUAGUCGCGUCAC 55.00%
Apta_793 RNA GGGAGAGAACAAUGACCUGCGGUGCCAAGCCGUCGGGUUAUGUUGAUCUCCUCAAGGACGAGUGCAUUGCAUCACGUCAGUAG 54.22%
Apta_549 RNA GGAGCUCAGCCUUCACUGCAUGAUAAACCGAUGCUGGGCGAUUCUCCUGAAGUAGGGGAAGAGUUGUCAUGUAUGGGGGCACCACGGUCGGAUCCUG 53.61%
Apta_256 RNA GGGCGCUAAGUCCUCGCUCAUGCGCGUCCCAUGGGGUAUAGAGGGGUCGAAGUGGACGCGCGACUCGGAUCCU 53.33%
Apta_612 RNA GGGCGACCCUGAUGAGCCUUAGGAUAUGCUUCGGCAGAAGGACGUCGAAACGGUGAAAGCCGUAGGUUGCCC 53.33%
Apta_1221 RNA GGAGGCGCCAACUGAAUGAACGAGUUGAAAUGCGGAUCAAGUUACUGCUUCGGCAGUACCUAGUGGGAAAAGUUCUUGGGUCCGUAACUAGUCGCGUCAC 53.00%
Apta_1225 RNA GGAGGCGCCAACUGAAUGAAAGAGGUAACGAAAGAUGAUUGUGCCUGCUUCGGCAGUACAACUUCUCGGAUAAAUGAUUAUCCGUAACUAGUCGCGUCAC 53.00%
Apta_1226 RNA GGAGGCGCCAACUGAAUGAAGGUGUAUUUCAGUUAAAGAACUUGCUGCUUCGGCAGCGUUCUGAGUUACUAGUCCAAUAAUCCGUAACUAGUCGCGUCAC 53.00%
Apta_559 RNA GGAUGUCCAGUCGCUUGCAAUGCCCUUUUAGACCCUGAUGAGGAUCAUCGGACUUUGUCCUGUGGAGUAAGAUCGCGAAACGGUGAAAGCCGUAGGUCU 52.53%
Apta_453 RNA GGGCUAGCUGAUCGUACCAGUAGCGUGGCCUGGGGGGCCUAGUCGUGCGAUACUAACAGCUAACACCC 52.00%
Apta_1222 RNA GGAGGCGCCAACUGAAUGAAACCGUGCUAAGGAGUUGGACUCCGCUGCUUCGGCAGAGCGAUAUAGUGCCAGCUGAUACAUCCGUAACUAGUCGCGUCAC 52.00%
Apta_724 RNA GGGAGAGGAUACUACUGUCAUACGUUAGGCUGUAGGCGAGGUGAAAUGAGCGGUAAUAGCCUCAGCGUAGCAUAUGCAUGAAUUCGAAGCUUCGC 51.58%
Apta_551 RNA GGAUGUCCAGUCGCUUGCAAUGCCCUUUUAGACCCUGAUGAGCGGUGCUAGUUAGUUGCAGUUUCGGUUGUUACGCGAAACGGUGAAAGCCGUAGGUCU 51.52%
Apta_720 RNA GGGAGAAUUCCGACCAGAAGCUUAGUAUAGCGAGGUUUAGCUACACUCGUGCUGAUCGUUUGGUACGGGACCUGCGUGUAGCCCAUAUGUGCGUCUACAUGGAUCCUCA 51.38%
Apta_816 RNA GGGUUCACUGCAGACUUGACGAAGCUUGAGAGAUGCCCCCUGAUGUGCAUUCUUGUUGUGUUGCGGCAAUGGAUCCACAUCUACGAAUUC 51.11%
Apta_1224 RNA GGAGGCGCCAACUGAAUGAAUGUUCUGGAUCUGCUAGAGACUAUCUGCUUCGGCAGCACUCUCCGUUAACAACACGUACAUCCGUAACUAGUCGCGUCAC 51.00%
Apta_719 RNA GGAAUGGAUCCACAUCUACGAAGGCUUUGAAGGUGAGACCGUGCAAAUGAGGAUGGUGUGGAUGAUUAGGGUUGUCGGUUUUCACUGCAGACUUGACGAAGCUU 50.96%
Apta_269 RNA AACGCUCAACGUCAGAAGGCAACGUAUAGGCAAGCACACUUCGACAUGAGGC 50.67%
Apta_304 RNA CGGCCGAUAGAAAGACUACUUGAGCCCUUAAAUGAGGUUAUGUGCGGCCG 50.67%